| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = -$1,191 ) |
| | 2022 | 2017 | COARE BIOTECHNOLOGY, INC. | 800 RESEARCH PARKWAY | OKLAHOMA CITY | OK | 73104-3611 | OKLAHOMA | USA | R44CA174025 | Development of Monoclonal Antibodies to Treat Pancreatic Cancer | 000 | 3 | NIH | 6/29/2022 | -$1,191 |
|
| Issue Date FY: 2021 ( Subtotal = -$415 ) |
| | 2021 | 2017 | COARE BIOTECHNOLOGY, INC. | 800 RESEARCH PARKWAY | OKLAHOMA CITY | OK | 73104-3611 | OKLAHOMA | USA | R44CA174025 | Development of Monoclonal Antibodies to Treat Pancreatic Cancer | 000 | 3 | NIH | 7/13/2021 | $0 |
| | 2021 | 2015 | COARE BIOTECHNOLOGY, INC. | 800 RESEARCH PARKWAY | OKLAHOMA CITY | OK | 73104-3611 | OKLAHOMA | USA | R43CA189436 | Development of an ADC against Pancreatic Cancer | 002 | 1 | NIH | 10/3/2020 | -$100 |
| | 2021 | 2015 | COARE BIOTECHNOLOGY, INC. | 800 RESEARCH PARKWAY | OKLAHOMA CITY | OK | 73104-3611 | OKLAHOMA | USA | R43CA186577 | Development of ADC to Target Tumor Stem Cells In Colorectal Cancer | 001 | 1 | NIH | 10/3/2020 | $16,076 |
| | 2021 | 2015 | COARE BIOTECHNOLOGY, INC. | 800 RESEARCH PARKWAY | OKLAHOMA CITY | OK | 73104-3611 | OKLAHOMA | USA | R43CA186577 | Development of ADC to Target Tumor Stem Cells In Colorectal Cancer | 000 | 1 | NIH | 10/1/2020 | -$16,076 |
| | 2021 | 2015 | COARE BIOTECHNOLOGY, INC. | 800 RESEARCH PARKWAY | OKLAHOMA CITY | OK | 73104-3611 | OKLAHOMA | USA | R43CA186577 | Development of ADC to Target Tumor Stem Cells In Colorectal Cancer | 002 | 1 | NIH | 10/3/2020 | -$315 |
| | 2021 | 2015 | COARE BIOTECHNOLOGY, INC. | 800 RESEARCH PARKWAY | OKLAHOMA CITY | OK | 73104-3611 | OKLAHOMA | USA | R43CA189436 | Development of an ADC against Pancreatic Cancer | 001 | 1 | NIH | 10/3/2020 | $22,338 |
| | 2021 | 2015 | COARE BIOTECHNOLOGY, INC. | 800 RESEARCH PARKWAY | OKLAHOMA CITY | OK | 73104-3611 | OKLAHOMA | USA | R43CA189436 | Development of an ADC against Pancreatic Cancer | 000 | 1 | NIH | 10/1/2020 | -$22,338 |
|
| Issue Date FY: 2019 ( Subtotal = $0 ) |
| | 2019 | 2017 | COARE BIOTECHNOLOGY, INC. | 800 RESEARCH PARKWAY | OKLAHOMA CITY | OK | 73104-3611 | OKLAHOMA | USA | R44CA174025 | Development of Monoclonal Antibodies to Treat Pancreatic Cancer | 000 | 3 | NIH | 8/21/2019 | $0 |
|
| Issue Date FY: 2017 ( Subtotal = $1,094,011 ) |
| | 2017 | 2017 | COARE BIOTECHNOLOGY, INC. | 800 RESEARCH PARKWAY | OKLAHOMA CITY | OK | 73104-3611 | OKLAHOMA | USA | R44CA174025 | Development of Monoclonal Antibodies to Treat Pancreatic Cancer | 000 | 3 | NIH | 6/27/2017 | $1,094,011 |
| | 2017 | 2015 | COARE BIOTECHNOLOGY, INC. | 800 RESEARCH PARKWAY | OKLAHOMA CITY | OK | 73104-3611 | OKLAHOMA | USA | R43CA186577 | Development of ADC to Target Tumor Stem Cells In Colorectal Cancer | 000 | 1 | NIH | 7/5/2017 | $0 |
| | 2017 | 2015 | COARE BIOTECHNOLOGY, INC. | 800 RESEARCH PARKWAY | OKLAHOMA CITY | OK | 73104-3611 | OKLAHOMA | USA | R43CA189436 | Development of an ADC against Pancreatic Cancer | 000 | 1 | NIH | 7/5/2017 | $0 |
|
| Issue Date FY: 2016 ( Subtotal = $905,989 ) |
| | 2016 | 2016 | COARE BIOTECHNOLOGY INC | 800 RESEARCH PARKWAY | OKLAHOMA CITY | OK | 73104 | OKLAHOMA | USA | R44CA174025 | Development of Monoclonal Antibodies to Treat Pancreatic Cancer | 000 | 2 | NIH | 7/22/2016 | $905,989 |
|
| Issue Date FY: 2015 ( Subtotal = $449,950 ) |
| | 2015 | 2015 | COARE BIOTECHNOLOGY INC | 800 RESEARCH PARKWAY | OKLAHOMA CITY | OK | 73104 | OKLAHOMA | USA | R43CA186577 | Development of ADC to Target Tumor Stem Cells In Colorectal Cancer | 000 | 1 | NIH | 4/7/2015 | $224,950 |
| | 2015 | 2015 | COARE BIOTECHNOLOGY INC | 800 RESEARCH PARKWAY | OKLAHOMA CITY | OK | 73104 | OKLAHOMA | USA | R43CA189436 | Development of an ADC against Pancreatic Cancer | 000 | 1 | NIH | 3/26/2015 | $225,000 |
|
| Issue Date FY: 2014 ( Subtotal = $146,053 ) |
| | 2014 | 2014 | COARE BIOTECHNOLOGY INC | 800 RESEARCH PARKWAY | OKLAHOMA CITY | OK | 73104 | OKLAHOMA | USA | R43CA174025 | Development of Monoclonal Antibodies To Treat Pancreatic Cancer | 001 | 1 | NIH | 9/16/2014 | $146,053 |
| | 2014 | 2013 | COARE BIOTECHNOLOGY INC | 800 RESEARCH PARKWAY | OKLAHOMA CITY | OK | 73104 | OKLAHOMA | USA | R43CA174025 | Development of Monoclonal Antibodies To Treat Pancreatic Cancer | 000 | 1 | NIH | 8/6/2014 | $0 |
|
| Issue Date FY: 2013 ( Subtotal = $220,099 ) |
| | 2013 | 2013 | COARE BIOTECHNOLOGY INC | 800 RESEARCH PARKWAY | OKLAHOMA CITY | OK | 73104 | OKLAHOMA | USA | R43CA174025 | Development of Monoclonal Antibodies To Treat Pancreatic Cancer | 000 | 1 | NIH | 7/1/2013 | $220,099 |
|
|
